Cargando…

Systematic Review of Safety of RTS,S with AS01 and AS02 Adjuvant Systems Using Data from Randomized Controlled Trials in Infants, Children, and Adults

BACKGROUND: Emergence of antimalarial drugs and insecticides resistance alarms scientists to develop a safe and effective malaria vaccine. A pre-erythrocytic malaria vaccine called RTS,S has made great strides. AIM: The review was aimed to assess the safety of the candidate malaria vaccine RTS,S wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Yihunie, Wubetu, Kebede, Bekalu, Tegegne, Bantayehu Addis, Getachew, Melese, Abebe, Dehnnet, Aschale, Yibeltal, Belew, Habtamu, Bahiru, Bereket
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024506/
https://www.ncbi.nlm.nih.gov/pubmed/36941908
http://dx.doi.org/10.2147/CPAA.S400155
_version_ 1784909121192984576
author Yihunie, Wubetu
Kebede, Bekalu
Tegegne, Bantayehu Addis
Getachew, Melese
Abebe, Dehnnet
Aschale, Yibeltal
Belew, Habtamu
Bahiru, Bereket
author_facet Yihunie, Wubetu
Kebede, Bekalu
Tegegne, Bantayehu Addis
Getachew, Melese
Abebe, Dehnnet
Aschale, Yibeltal
Belew, Habtamu
Bahiru, Bereket
author_sort Yihunie, Wubetu
collection PubMed
description BACKGROUND: Emergence of antimalarial drugs and insecticides resistance alarms scientists to develop a safe and effective malaria vaccine. A pre-erythrocytic malaria vaccine called RTS,S has made great strides. AIM: The review was aimed to assess the safety of the candidate malaria vaccine RTS,S with AS01 and AS02 adjuvants using data from Phase I–III randomized controlled clinical trials (RCTs). METHODS: This systematic review was conducted based on PRISMA 2020. Regardless of time of publication year, all articles related with safety of RTS,S, RCTs published in the English language were included in the study. The last search of databases, and registry was conducted on 30 May, 2022. Pubmed, Google Scholar, Cochrane Library, Wiley Online Library, and Clinical trials.gov were thoroughly searched for accessible RCTs on the safety of RTS,S malaria vaccine. The studies were screened in three steps: duplicate removal, title and abstract screening, and full-text review. The included studies’ bias risk was assessed using the Cochrane risk of bias tool for RCTs. This systematic review is registered at Prospero (registration number: CRD42021285888). The qualitative descriptive findings from the included published studies were reported stratified by clinical trial phases. FINDINGS: A total of thirty-five eligible safety studies were identified. Injection site pain and swelling, febrile convulsion, fever, headache, meningitis, fatigue, gastroenteritis, myalgia, pneumonia, reactogenicity, and anemia were the most commonly reported adverse events. Despite few clinical trials reported serious adverse events, none of them were related to vaccination. CONCLUSION: Most of the adverse events observed from RTS,S/AS01 and RTS,S/AS02 malaria vaccines were reported in the control group and shared by other vaccines. Hence, the authors concluded that both RTS,S/AS01 and RTS,S/AS02 malaria vaccines are safe.
format Online
Article
Text
id pubmed-10024506
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-100245062023-03-19 Systematic Review of Safety of RTS,S with AS01 and AS02 Adjuvant Systems Using Data from Randomized Controlled Trials in Infants, Children, and Adults Yihunie, Wubetu Kebede, Bekalu Tegegne, Bantayehu Addis Getachew, Melese Abebe, Dehnnet Aschale, Yibeltal Belew, Habtamu Bahiru, Bereket Clin Pharmacol Review BACKGROUND: Emergence of antimalarial drugs and insecticides resistance alarms scientists to develop a safe and effective malaria vaccine. A pre-erythrocytic malaria vaccine called RTS,S has made great strides. AIM: The review was aimed to assess the safety of the candidate malaria vaccine RTS,S with AS01 and AS02 adjuvants using data from Phase I–III randomized controlled clinical trials (RCTs). METHODS: This systematic review was conducted based on PRISMA 2020. Regardless of time of publication year, all articles related with safety of RTS,S, RCTs published in the English language were included in the study. The last search of databases, and registry was conducted on 30 May, 2022. Pubmed, Google Scholar, Cochrane Library, Wiley Online Library, and Clinical trials.gov were thoroughly searched for accessible RCTs on the safety of RTS,S malaria vaccine. The studies were screened in three steps: duplicate removal, title and abstract screening, and full-text review. The included studies’ bias risk was assessed using the Cochrane risk of bias tool for RCTs. This systematic review is registered at Prospero (registration number: CRD42021285888). The qualitative descriptive findings from the included published studies were reported stratified by clinical trial phases. FINDINGS: A total of thirty-five eligible safety studies were identified. Injection site pain and swelling, febrile convulsion, fever, headache, meningitis, fatigue, gastroenteritis, myalgia, pneumonia, reactogenicity, and anemia were the most commonly reported adverse events. Despite few clinical trials reported serious adverse events, none of them were related to vaccination. CONCLUSION: Most of the adverse events observed from RTS,S/AS01 and RTS,S/AS02 malaria vaccines were reported in the control group and shared by other vaccines. Hence, the authors concluded that both RTS,S/AS01 and RTS,S/AS02 malaria vaccines are safe. Dove 2023-03-14 /pmc/articles/PMC10024506/ /pubmed/36941908 http://dx.doi.org/10.2147/CPAA.S400155 Text en © 2023 Yihunie et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Yihunie, Wubetu
Kebede, Bekalu
Tegegne, Bantayehu Addis
Getachew, Melese
Abebe, Dehnnet
Aschale, Yibeltal
Belew, Habtamu
Bahiru, Bereket
Systematic Review of Safety of RTS,S with AS01 and AS02 Adjuvant Systems Using Data from Randomized Controlled Trials in Infants, Children, and Adults
title Systematic Review of Safety of RTS,S with AS01 and AS02 Adjuvant Systems Using Data from Randomized Controlled Trials in Infants, Children, and Adults
title_full Systematic Review of Safety of RTS,S with AS01 and AS02 Adjuvant Systems Using Data from Randomized Controlled Trials in Infants, Children, and Adults
title_fullStr Systematic Review of Safety of RTS,S with AS01 and AS02 Adjuvant Systems Using Data from Randomized Controlled Trials in Infants, Children, and Adults
title_full_unstemmed Systematic Review of Safety of RTS,S with AS01 and AS02 Adjuvant Systems Using Data from Randomized Controlled Trials in Infants, Children, and Adults
title_short Systematic Review of Safety of RTS,S with AS01 and AS02 Adjuvant Systems Using Data from Randomized Controlled Trials in Infants, Children, and Adults
title_sort systematic review of safety of rts,s with as01 and as02 adjuvant systems using data from randomized controlled trials in infants, children, and adults
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024506/
https://www.ncbi.nlm.nih.gov/pubmed/36941908
http://dx.doi.org/10.2147/CPAA.S400155
work_keys_str_mv AT yihuniewubetu systematicreviewofsafetyofrtsswithas01andas02adjuvantsystemsusingdatafromrandomizedcontrolledtrialsininfantschildrenandadults
AT kebedebekalu systematicreviewofsafetyofrtsswithas01andas02adjuvantsystemsusingdatafromrandomizedcontrolledtrialsininfantschildrenandadults
AT tegegnebantayehuaddis systematicreviewofsafetyofrtsswithas01andas02adjuvantsystemsusingdatafromrandomizedcontrolledtrialsininfantschildrenandadults
AT getachewmelese systematicreviewofsafetyofrtsswithas01andas02adjuvantsystemsusingdatafromrandomizedcontrolledtrialsininfantschildrenandadults
AT abebedehnnet systematicreviewofsafetyofrtsswithas01andas02adjuvantsystemsusingdatafromrandomizedcontrolledtrialsininfantschildrenandadults
AT aschaleyibeltal systematicreviewofsafetyofrtsswithas01andas02adjuvantsystemsusingdatafromrandomizedcontrolledtrialsininfantschildrenandadults
AT belewhabtamu systematicreviewofsafetyofrtsswithas01andas02adjuvantsystemsusingdatafromrandomizedcontrolledtrialsininfantschildrenandadults
AT bahirubereket systematicreviewofsafetyofrtsswithas01andas02adjuvantsystemsusingdatafromrandomizedcontrolledtrialsininfantschildrenandadults